[Lymphocytic colitis likely attributable to use of vinburnine (Cervoxan)].
E
E
Chauveau
J M
JM
Prignet
E
E
Carloz
J L
JL
Duval
B
B
Gilles
D003092:Colitis / Q000139:chemically induced* / Q000150:complications / Q000473:pathology; D003638:Deafness / Q000150:complications / Q000188:drug therapy; D003967:Diarrhea / Q000139:chemically induced / Q000150:complications / Q000473:pathology; D006801:Humans; D018655:Lymphocyte Count; D008214:Lymphocytes; D008297:Male; D008875:Middle Aged; D014665:Vasodilator Agents / Q000009:adverse effects*; D014748:Vinca Alkaloids / Q000009:adverse effects*
D014665:Vasodilator Agents; D014748:Vinca Alkaloids; C016422:eburnamonine
Colite lymphocytaire vraisemblablement imputable à la prise de vinburnine (Cervoxan).